Skip to main content
. Author manuscript; available in PMC: 2017 Oct 25.
Published in final edited form as: Chem Biol Interact. 2016 Aug 16;258:21–29. doi: 10.1016/j.cbi.2016.08.010

Figure 3.

Figure 3

Effect of epigenetic inhibitors on cisplatin- and CFZ-induced cytotoxicity in prostate cancer cells. LNCaP (A) cells were combinatorial treated with TSA and cisplatin and PC-3 (B) cells with 5-Aza and CFZ. The effect on cytotoxicity was measured using MTT staining and data are indicative of results from 6 separate passages per cell line (n ≥ 6) and are expressed as mean ± SD. (* p < 0.05 compared to control, # p < 0.05 compared to respective chemotherapeutic treatment alone by One-way ANOVA followed by Bonferonni post-hoc test)